Combined evaluation of centromere protein H and Ki-67 as prognostic biomarker for patients with gastric carcinoma

European Journal of Surgical Oncology

Volumn 39, Issue 2, 2013, Pages 141-149

  He, W L ^a   Li, Y H ^b   Yang, D J ^a   Song, W ^a   Chen, X L ^c   Liu, F K ^a   Wang, Z ^a   Li, W ^a   Chen, W ^a   Chen, C Y ^a   He, Y L ^a   Zhan, W H ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c GUANGZHOU UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Centromere protein H; Ki 67; Prognostic biomarker; Survival curve; Survivin

Indexed keywords

CENTROMERE PROTEIN H; CHROMOSOME PROTEIN; KI 67 ANTIGEN; MESSENGER RNA; SMALL INTERFERING RNA; SURVIVIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INVASION; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURVIVAL; CANCER TISSUE; CELL FUNCTION; CELL PROLIFERATION; CLINICAL FEATURE; CLONOGENIC ASSAY; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; STOMACH CARCINOMA; TISSUE MICROARRAY; TUMOR VOLUME; WESTERN BLOTTING;

AGED; BLOTTING, WESTERN; CARCINOMA; CELL LINE, TUMOR; CENTROMERE; CHROMOSOMAL PROTEINS, NON-HISTONE; FACTOR ANALYSIS, STATISTICAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; KAPLAN-MEIER ESTIMATE; KI-67 ANTIGEN; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; STOMACH NEOPLASMS; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 84872149859     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2012.08.023     Document Type: Article

References (30)

1. M.A. Shah, and D.P. Kelsen Gastric cancer: a primer on the epidemiology and biology of the disease and an overview of the medical management of advanced disease J Natl Compr Canc Netw 8 2010 437 447
2. R.S. Gill, D.P. Al-Adra, and J. Nagendran Treatment of gastric cancer with peritoneal carcinomatosis by cytoreductive surgery and HIPEC: a systematic review of survival, mortality, and morbidity J Surg Oncol 104 2011 692 698
3. T. Fukagawa, Y. Mikami, and A. Nishihashi CENP-H, a constitutive centromere component, is required for centromere targeting of CENP-C in vertebrate cells EMBO J 20 2001 4603 4617 (Pubitemid 32772053)
4. N. Sugata, S. Li, and W.C. Earnshaw Human CENP-H multimers colocalize with CENP-A and CENP-C at active centromere-kinetochore complexes Hum Mol Genet 9 2000 2919 2926
5. R. Scully The spindle-Assembly checkpoint, aneuploidy, and gastrointestinal cancer N Engl J Med 363 2010 2665 2666
6. T. Tomonaga, K. Matsushita, and M. Ishibashi Centromere protein H is up-regulated in primary human colorectal cancer and its overexpression induces aneuploidy Cancer Res 65 2005 4683 4689 (Pubitemid 40740804)
7. H. Shigeishi, K. Higashikawa, and S. Ono Increased expression of CENP-H gene in human oral squamous cell carcinomas harboring high-proliferative activity Oncol Rep 16 2006 1071 1075
8. W.T. Liao, X. Wang, and L.H. Xu Centromere protein H is a novel prognostic marker for human nonsmall cell lung cancer progression and overall patient survival Cancer 115 2009 1507 1517
9. W.T. Liao, L.B. Song, and H.Z. Zhang Centromere protein H is a novel prognostic marker for nasopharyngeal carcinoma progression and overall patient survival Clin Cancer Res 13 2007 508 514
10. W.T. Liao, Y. Feng, and M.L. Li Overexpression of centromere protein H is significantly associated with breast cancer progression and overall patient survival Chin J Cancer 30 2011 627 637
11. X.Z. Guo, G. Zhang, and J.Y. Wang Prognostic relevance of centromere protein H expression in esophageal carcinoma BMC Cancer 8 2008 233
12. W.T. Liao, C.P. Yu, and D.H. Wu Upregulation of CENP-H in tongue cancer correlates with poor prognosis and progression J Exp Clin Cancer Res 28 2009 74
13. K. Lowe, A. Khithani, and E. Liu Ki-67 labeling: a more sensitive indicator of malignant phenotype than mitotic count or tumor size? J Surg Oncol 2012
14. K.E. Bani-Hani, N.M. Almasri, and Y.S. Khader Combined evaluation of expressions of cyclin E and p53 proteins as prognostic factors for patients with gastric cancer Clin Cancer Res 11 2005 1447 1453 (Pubitemid 40315225)
15. P. Lauren The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification Acta Pathol Microbiol Scand 64 1965 31 49
16. D.L. Rimm, T.O. Nielsen, and S.D. Jewell Cancer and Leukemia group B pathology committee guidelines for tissue microarray construction representing multicenter prospective clinical trial tissues J Clin Oncol 29 2011 2282 2290
17. P. Zhao, Y. Li, and Y. Lu Aberrant expression of CD133 protein correlates with Ki-67 expression and is a prognostic marker in gastric adenocarcinoma BMC Cancer 10 2010 218
18. Y. Li, S. Liu, and Z. Zhang RAGE mediates accelerated diabetic vein graft atherosclerosis induced by combined mechanical stress and AGEs via synergistic ERK activation PLoS One 7 2012 e35016
19. K. Shomori, K. Nishihara, and T. Tamura Geminin, Ki67, and minichromosome maintenance 2 in gastric hyperplastic polyps, adenomas, and intestinal-type carcinomas: pathobiological significance Gastric Cancer 13 2010 177 185
20. N.E. Tzanakis, G. Peros, and P. Karakitsos Prognostic significance of p53 and Ki67 proteins expression in greek gastric cancer patients Acta Chir Belg 109 2009 606 611
21. T. Quan, B. He, and T. Liu Role of centromere protein H in human gastric cancer cell proliferation Nan Fang Yi Ke Da Xue Xue Bao 32 2012 265 269
22. A. Carvalho, M. Carmena, and C. Sambade Survivin is required for stable checkpoint activation in taxol-treated HeLa cells J Cell Sci 116 2003 2987 2998 (Pubitemid 36926987)
23. D.C. Altieri Survivin, versatile modulation of cell division and apoptosis in cancer Oncogene 22 2003 8581 8589 (Pubitemid 38019195)
24. S.M. Lens, G. Vader, and R.H. Medema The case for survivin as mitotic regulator Curr Opin Cell Biol 18 2006 616 622 (Pubitemid 44711886)
25. F. Li, G. Ambrosini, and E.Y. Chu Control of apoptosis and mitotic spindle checkpoint by survivin Nature 396 1998 580 584 (Pubitemid 28563719)
26. H. Meng, C. Lu, H. Mabuchi, and N. Tanigawa Prognostic significance and different properties of survivin splicing variants in gastric cancer Cancer Lett 216 2004 147 155 (Pubitemid 39463318)
27. N. Kanda, H. Seno, and Y. Konda STAT3 is constitutively activated and supports cell survival in association with survivin expression in gastric cancer cells Oncogene 23 2004 4921 4929 (Pubitemid 38932164)
28. E. Okada, Y. Murai, and K. Matsui Survivin expression in tumor cell nuclei is predictive of a favorable prognosis in gastric cancer patients Cancer Lett 163 2001 109 116 (Pubitemid 32121836)
29. C. Yao, J. Liu, and L. Shao Rapamycin inhibits the proliferation and apoptosis of gastric cancer cells by down regulating the expression of survivin Hepatogastroenterology 58 2011 1075 1080
30. Z. Wenying, J. Zhaoning, and Y. Zhimin Survivin siRNA inhibits gastric cancer in nude mice Cell Biochem Biophys 2011